OncoMed Pharmaceuticals (OncoMed Pharmaceuticals) Revenue : $44.42 Mil (TTM As of Dec. 2018)

OncoMed Pharmaceuticals Revenue Chart

OncoMed Pharmaceuticals Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Revenue		Get a 7-Day Free Trial				39.56	25.90	25.15	38.15	44.42

OncoMed Pharmaceuticals Quarterly Data
	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18
Revenue	Get a 7-Day Free Trial															20.64	7.85	6.87	19.52	10.18

Competitive Comparison of OncoMed Pharmaceuticals's Revenue

For the Biotechnology subindustry, OncoMed Pharmaceuticals's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoMed Pharmaceuticals's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoMed Pharmaceuticals's Revenue distribution charts can be found below:

* The bar in red indicates where OncoMed Pharmaceuticals's Revenue falls into.

OncoMed Pharmaceuticals Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoMed Pharmaceuticals  (NAS:OMED) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

OncoMed Pharmaceuticals Revenue Related Terms

Thank you for viewing the detailed overview of OncoMed Pharmaceuticals's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoMed Pharmaceuticals (OncoMed Pharmaceuticals) Business Description